BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250401
DTEND;VALUE=DATE:20250406
DTSTAMP:20260422T231544
CREATED:20240822T064229Z
LAST-MODIFIED:20250319T091838Z
UID:55175-1743465600-1743897599@www.braincouncil.eu
SUMMARY:International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders AD/PD 2025
DESCRIPTION:International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological DisordersThe AD/PD™ Alzheimer’s disease and Parkinson’s disease Conference will present all the latest breakthroughs in treatment\, translational R&D\, early diagnosis\, drug development and clinical trials in Alzheimer’s\, Parkinson’s and other related neurological disorders. The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference remains at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s\, Parkinson’s\, and other related neurodegenerative diseases. AD/PD™ Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease\, prevention\, and therapy. \nThe AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases\, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting\, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders. \nThe forthcoming AD/PD™ meeting\, in 2025 will take place as a Hybrid Conference in the enchanting city of Vienna\, Austria\, and online. \nLearn More
URL:https://www.braincouncil.eu/event/ad-pd-2025/
LOCATION:Vienna\, Austria
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/08/ADPD_conference.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250405
DTEND;VALUE=DATE:20250409
DTSTAMP:20260422T231544
CREATED:20240424T130841Z
LAST-MODIFIED:20250326T150704Z
UID:53963-1743811200-1744156799@www.braincouncil.eu
SUMMARY:33rd European Congress of Psychiatry
DESCRIPTION:The 33rd European Congress of Psychiatry will take place on 5-8 April 2025 in Madrid\, Spain. \nThe European Psychiatric Association (EPA) community is growing fast\, as testified by the increasing number of members and the numerous activities the EPA is organising. Many of the community members are young and clinically oriented\, and it is this clinical orientation that is highlighted in the motto of the 2025 Madrid Congress “Towards Real-World Solutions in Mental Health”. Next to excellent and ground-breaking research\, one of the core interests of EPA is the clinical translation of these findings and the sharing of good practices. \nEBC President Suzanne Dickson will speak in a joint workshop on ‘No Health Without Brain Health & the Brain Health Mission: Raising Awareness & Putting the Brain on the Top of the Policy Agenda’. This workshop represents a collaboration between EPA\, the European Academy of Neurology (EAN)\, the Federation of European Neuroscience Societies (FENS) and EBC. \nWe will also present an e-poster on the second phase of the Rethinking Schizophrenia project\, co-created by the European Brain Council (EBC) and the European Psychiatric Association (EPA). This report looks at ways to optimise the care pathway\, from the first episode of psychosis to long-term care. \nFurthermore\, EBC is pleased to be present at booth 14C in the exhibition space. Come and find us to learn more about our ongoing activities\, projects and the upcoming events! \nEBC is looking forward to seeing you and the whole EPA community in Madrid! \nLearn more about the joint workshop ‘No Health Without Brain Health & the Brain Health Mission’: \nLearn more about the e-poster presentation on the Rethinking Schizophrenia Care Pathways project: \nVisit the official congress website and learn more:
URL:https://www.braincouncil.eu/event/33rd-european-congress-of-psychiatry/
LOCATION:Madrid\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/04/EPA-2025-Home-Page-Cover-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250406T123000
DTEND;TZID=Europe/Paris:20250406T131500
DTSTAMP:20260422T231544
CREATED:20250103T110338Z
LAST-MODIFIED:20250331T074748Z
UID:55893-1743942600-1743945300@www.braincouncil.eu
SUMMARY:Rethinking Schizophrenia: Care Pathways | European Congress of Psychiatry
DESCRIPTION:EBC is pleased to have an e-poster viewing “Rethinking Pathways: Innovative Approaches to Identify Individuals Experiencing First-Episode Psychosis and Connect Them to Care” at the upcoming European Congress of Psychiatry\, set to take place on 5-8 April 2025 in Madrid (Spain). The e-poster EPP178 will be presented from 12:30 – 13:15 on 6 April 2025 in the e-poster area (station 13). \nThe e-poster will feature the second phase of the Rethinking schizophrenia project\, co-created by the European Brain Council (EBC) and the European Psychiatric Association (EPA)\, and will aim to examine health gains and societal impacts resulting from optimal healthcare interventions in comparison with current care or inadequate treatment. Additionally\, this projects convert data evidence to policy recommendations on how to improve the care pathways. \nWith a typical onset during late adolescence or early adulthood\, schizophrenia requires lifelong treatment\, combining pharmacological and non-pharmacological approaches. Early symptom recognition and timely interventions can greatly enhance functional recovery\, however recent reports have identified significant gaps in access to timely assessment and shared decision-making\, compounded by the unprecedented demand for mental healthcare among young people. Such high demands create challenges for health care services in delivering not only timely and evidence-based care but also safe and person-centred\, as recommended by the World Health Organization. There is a need to improve prevention and care of young individuals with first episode psychosis (the onset of schizophrenia) to safely and effectively transition between various types of care tailored according to individual needs. \nTo address these issues\, the Rethinking Schizophrenia project is conducting an analysis of patient care pathways across nine European countries (Belgium\, Denmark\, France\, Germany\, Hungary\, Italy\, Poland\, Spain\, and the UK). This project aims to put forward an in-depth patient care pathway analysis in order to define specific strategies to advance the prevention and treatment of schizophrenia. Findings will inform policy recommendations to enhance care pathways for young individuals experiencing first-episode psychosis. \nPavel MohrVice-President\, Czech Psychiatric AssociationGraduated from the Medical Faculty\, Charles University Prague in 1990 (M.D.); in 2001 obtained his Ph.D. in Neurosciences.\, in 2015 was appointed a Professor of Psychiatry at the Charles University in Prague. Since 1991\, prof. Mohr works at the National Institute of Mental Health\, Czechia (formerly the Prague Psychiatric Center)\, currently as the Clinical Director. From 1995 to 1998\, he was a visiting scientist at the Nathan Kline Institute for Psychiatric Research in Orangeburg\, New York. Dr. Mohr is a Professor of Psychiatry at the 3rd Medical Faculty\, Charles University\, teaching pre-graduate medical students in psychiatry and postgraduate students in the PhD program of Neurosciences. Between 2006 and 2009 was a Faculty member of the Vienna School of Clinical Research. Member of the EPA since 2000\, (since 2023 member of the EPA Board\, current Chair of the Psychopharmacology Section\, member of the Section Neurodevelopmental disorders across the lifespan); representative of the Czech Psychiatric Association at the Council of the NPAs EPA; since 2012 member of the European Network Adult ADHD; member of the European Group for Research in Schizophrenia (EGRIS); current Vice-President of the Czech Psychiatric Association (President 2019-2022)\, Board Member of the Czech Neuro-psychopharmacological Society (President 2009-2011). His main research interests are Clinical Psychiatry and Neurosciences; prof. Mohr has been a principal investigator of numerous research projects funded by the national and international research foundations. \nLearn more about the EBC activities at the Congress:
URL:https://www.braincouncil.eu/event/rethinking-schizophrenia-care-pathways-european-congress-of-psychiatry/
LOCATION:Madrid\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2025/01/RETHINK-Schizophrenia_Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250407T150000
DTEND;TZID=UTC:20250407T163000
DTSTAMP:20260422T231544
CREATED:20250205T092100Z
LAST-MODIFIED:20250326T145739Z
UID:56160-1744038000-1744043400@www.braincouncil.eu
SUMMARY:Joint Workshop at EPA 2025: "No Health Without Brain Health & the Brain Health Mission: Raising Awareness & Putting the Brain on the Top of the Policy Agenda"
DESCRIPTION:Joint Workshop at EPA 2025 Congress: “No Health Without Brain Health & the Brain Health Mission: Raising Awareness & Putting the Brain on the Top of the Policy Agenda” \nThe European Psychiatric Association (EPA) community is growing fast\, as testified by the increasing number of members and the numerous activities the EPA is organising. Many of the community members are young and clinically oriented\, and it is this clinical orientation that is highlighted in the motto of the 2025 Madrid Congress “Towards Real-World Solutions in Mental Health”. Next to excellent and ground-breaking research\, one of the core interests of EPA is the clinical translation of these findings and the sharing of good practices. \nEBC President Suzanne Dickson will speak during a joint workshop on ‘No Health Without Brain Health & the Brain Health Mission: Raising Awareness & Putting the Brain on the Top of the Policy Agenda’. This workshop represents a collaboration between EPA\, the European Academy of Neurology (EAN)\, the Federation of European Neuroscience Societies (FENS) and EBC. Other speakers of this workshop include Peter Falkai\, EBC Treasurer\, Paul Boon\, Past EAN President and Tomás Ryan\, Neuroscientist at Trinity College Dublin. \nSociety is facing brain challenges like never before — improving the health and wellbeing of citizens has become the top priority for many governments and brain health should not be left behind. The No Health Without Brain Health campaign aims to put a spotlight on the urgency of addressing the growing burden\, the socioeconomic impacts and the need to significantly increase investment in the brain R&D space. You can learn more about the No Health Without Brain Health campaign here. \nSimilarly\, EAN’s Brain Health Mission has several aims:\n • Ensure a basic understanding of how to optimise brain health is available to the public through all stages of their lives and the lives of their loved ones\n • Support & disseminate public health strategies which can make a meaningful and long-term impact on brain health\n • Boost the workforces of healthcare professionals within neurology\, as well as professionals dedicated to mental health\, to ensure patients and those affected by brain disorders receive the care and support they need and deserve.\nTo achieve this\, effective prevention\, early detection\, and intervention strategies are equally important\, as well as investments in research\, innovative treatments\, and integrated healthcare systems. The collaborative Brain Health Mission is rooted in evidence-based research that underscores the importance of a holistic approach to brain and mental health\, and to the needs of people\, patients\, and their carers and families. \nThis workshop will take place in Auditoriom A from 15:00 – 16:30 on Monday April 7\, 2025.\nWorkshop Agenda:\nChairs: Paul Boon & Peter Falkai \n15:00 – 15:16: Brain and mental: two sides of the same coin (Speaker: Peter Falkai\, Treasurer\, EBC)\n15:16 – 15:32: The Brain Health Mission: a collaborative to raise awareness (Speaker: Paul Boon\, Past President\, EAN)\n15:32 – 15:48: How to develop a national brain strategy – The Norwegian Way (Speaker: Jana Middelfart-Hoff\, Treasurer\, European Academy of Neurology) \n15:48 – 16:04: Discovery Neuroscience and Brain Health (Speaker: Tomás Ryan\, Neuroscientist\, Trinity College Dublin)\n16:04 – 16:20: No Health Without Brain Health: Prioritising Brain Health in the European Union to Leave No One Behind (Speaker: Suzanne Dickson\, President\, EBC)\n16:20 – 16:30: Q&A \nSuzanne L. DicksonPresident\, European Brain CouncilSuzanne L Dickson is a neurobiologist and Professor of Neuroendocrinology at the University of Gothenburg. She graduated with a Ph.D. in Neuroendocrinology from the University of Cambridge in 1993\, where she later became Senior Lecturer in Physiology. She is a leading figure in neuroendocrinology and works within many European Union and international organisations and societies to promote research\, facilitate grant funding and training of Early Career Scientists. Her research into the neurobiology of appetite aims to unravel neurobiological pathways that respond to orexigenic signals\, such as the hormone\, ghrelin\, and that drive feeding behaviours\, not only food intake but also food choice\, food anticipation\, food reward and food motivation. This work involves mostly preclinical studies and includes behavioural tasks\, viral vector mapping\, chemogenetics and RNAscope. She is President of the European Brain Council and Secretary of the European College for Neuropsychopharmacology. \nEBC is looking forward to seeing you and the whole EPA community in Madrid! \nEBC’s participation in the EPA 2025 congress goes beyond this advocacy workshop. Come find our e-poster presentation on the Rethinking Schizophrenia Care Pathway project and do not hesitate to stop by our booth in the exhibition space to learn more about EBC’s current projects and upcoming events! \nLearn more about the e-poster presentation on the Rethinking Schizophrenia Care Pathways project: \nVisit the official congress website and Programme:
URL:https://www.braincouncil.eu/event/joint-workshop-at-epa-2025/
LOCATION:Madrid\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/04/Suzanne-Dickson-EPA2025.png
END:VEVENT
END:VCALENDAR